FDA Import Refusal 8NP-0151205-6/10002/2 — Stallion Laboratories Private Limited
The FDA refused shipment 8NP-0151205-6/10002/2 from Stallion Laboratories Private Limited (India) on Aug 11, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 11, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 118,75